The global market for Peptide CDMO Services was valued at US$ 4235 million in the year 2024 and is projected to reach a revised size of US$ 11090 million by 2031, growing at a CAGR of 15.0% during the forecast period.

Peptide CDMO Services Market

Peptide CDMO Services refer to the specialized contract development and manufacturing services offered by third-party organizations to assist pharmaceutical companies in the production of peptide-based therapeutics. These services typically include peptide synthesis, purification, formulation, and analytical testing to ensure that the peptides meet required quality, purity, and stability standards. CDMOs in this sector provide the expertise and infrastructure needed for large-scale production, offering cost-effective solutions and faster time-to-market for peptide drugs. With the growing demand for personalized medicines and the increasing role of peptides in treating various diseases, including cancer, diabetes, and neurological disorders, peptide CDMOs play a crucial role in the development and manufacturing of peptide therapeutics.

The demand for Peptide CDMO (Contract Development and Manufacturing Organization) services is driven by the growing focus on peptide-based therapeutics in the pharmaceutical industry. Peptides are becoming increasingly important in treating a wide range of diseases, including cancer, endocrine disorders, neurological conditions, and autoimmune diseases, due to their ability to offer high specificity, targeted delivery, and fewer side effects compared to traditional small molecules. As the complexity of peptide drugs increases, pharmaceutical companies are increasingly outsourcing the development and manufacturing of these drugs to Peptide CDMOs, which offer specialized expertise, advanced technologies, and scalable production capabilities. This trend is amplified by the rise in biopharmaceutical outsourcing, with companies looking to reduce time-to-market and costs while focusing on their core competencies in research and development.Despite the growing demand for peptide CDMO services, the market faces challenges related to the complexity and cost of peptide synthesis and manufacturing. Peptides often require specialized technologies for synthesis, purification, and formulation, which can make the process both expensive and time-consuming. The production of high-quality peptides at large scale involves significant technical hurdles, such as ensuring purity, stability, and yield, which increases operational costs for CDMOs. Additionally, regulatory hurdles pose a challenge, as peptides often require more stringent oversight compared to traditional drugs. This includes the need for comprehensive documentation, clinical trials, and compliance with GMP (Good Manufacturing Practices). These factors may limit the ability of some smaller CDMOs to compete effectively, making it difficult for them to meet the increasing demand while ensuring high-quality standards..

This report aims to provide a comprehensive presentation of the global market for Peptide CDMO Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide CDMO Services.

The Peptide CDMO Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Peptide CDMO Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Peptide CDMO Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Peptide CDMO Services Market Report

Report Metric	Details
Report Name	Peptide CDMO Services Market
Accounted market size in year	US$ 4235 million
Forecasted market size in 2031	US$ 11090 million
CAGR	15.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	APIs and Intermediates FDF
Segment by Application	Commercial Academic Research Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bachem, PolyPeptide, CordenPharma, AmbioPharm, USV Peptides, Thermofischer, Bio Basic, JPT, Genscript, Xinbang Pharma, ScinoPharm, SN Biopharm, CBL, Piramal Pharma, CPC Scientific
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Peptide CDMO Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Peptide CDMO Services Market growing?

Ans: The Peptide CDMO Services Market witnessing a CAGR of 15.0% during the forecast period 2025-2031.

What is the Peptide CDMO Services Market size in 2031?

Ans: The Peptide CDMO Services Market size in 2031 will be US$ 11090 million.

Who are the main players in the Peptide CDMO Services Market report?

Ans: The main players in the Peptide CDMO Services Market are Bachem, PolyPeptide, CordenPharma, AmbioPharm, USV Peptides, Thermofischer, Bio Basic, JPT, Genscript, Xinbang Pharma, ScinoPharm, SN Biopharm, CBL, Piramal Pharma, CPC Scientific

What are the Application segmentation covered in the Peptide CDMO Services Market report?

Ans: The Applications covered in the Peptide CDMO Services Market report are Commercial, Academic Research, Other

What are the Type segmentation covered in the Peptide CDMO Services Market report?

Ans: The Types covered in the Peptide CDMO Services Market report are APIs and Intermediates, FDF

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Peptide CDMO Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 APIs and Intermediates

1.2.3 FDF

1.3 Market by Application

1.3.1 Global Peptide CDMO Services Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Commercial

1.3.3 Academic Research

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Peptide CDMO Services Market Perspective (2020-2031)

2.2 Global Peptide CDMO Services Growth Trends by Region

2.2.1 Global Peptide CDMO Services Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Peptide CDMO Services Historic Market Size by Region (2020-2025)

2.2.3 Peptide CDMO Services Forecasted Market Size by Region (2026-2031)

2.3 Peptide CDMO Services Market Dynamics

2.3.1 Peptide CDMO Services Industry Trends

2.3.2 Peptide CDMO Services Market Drivers

2.3.3 Peptide CDMO Services Market Challenges

2.3.4 Peptide CDMO Services Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Peptide CDMO Services Players by Revenue

3.1.1 Global Top Peptide CDMO Services Players by Revenue (2020-2025)

3.1.2 Global Peptide CDMO Services Revenue Market Share by Players (2020-2025)

3.2 Global Top Peptide CDMO Services Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Peptide CDMO Services Revenue

3.4 Global Peptide CDMO Services Market Concentration Ratio

3.4.1 Global Peptide CDMO Services Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Peptide CDMO Services Revenue in 2024

3.5 Global Key Players of Peptide CDMO Services Head office and Area Served

3.6 Global Key Players of Peptide CDMO Services, Product and Application

3.7 Global Key Players of Peptide CDMO Services, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Peptide CDMO Services Breakdown Data by Type

4.1 Global Peptide CDMO Services Historic Market Size by Type (2020-2025)

4.2 Global Peptide CDMO Services Forecasted Market Size by Type (2026-2031)

5 Peptide CDMO Services Breakdown Data by Application

5.1 Global Peptide CDMO Services Historic Market Size by Application (2020-2025)

5.2 Global Peptide CDMO Services Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Peptide CDMO Services Market Size (2020-2031)

6.2 North America Peptide CDMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Peptide CDMO Services Market Size by Country (2020-2025)

6.4 North America Peptide CDMO Services Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Peptide CDMO Services Market Size (2020-2031)

7.2 Europe Peptide CDMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Peptide CDMO Services Market Size by Country (2020-2025)

7.4 Europe Peptide CDMO Services Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Peptide CDMO Services Market Size (2020-2031)

8.2 Asia-Pacific Peptide CDMO Services Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Peptide CDMO Services Market Size by Region (2020-2025)

8.4 Asia-Pacific Peptide CDMO Services Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Peptide CDMO Services Market Size (2020-2031)

9.2 Latin America Peptide CDMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Peptide CDMO Services Market Size by Country (2020-2025)

9.4 Latin America Peptide CDMO Services Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Peptide CDMO Services Market Size (2020-2031)

10.2 Middle East & Africa Peptide CDMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Peptide CDMO Services Market Size by Country (2020-2025)

10.4 Middle East & Africa Peptide CDMO Services Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Bachem

11.1.1 Bachem Company Details

11.1.2 Bachem Business Overview

11.1.3 Bachem Peptide CDMO Services Introduction

11.1.4 Bachem Revenue in Peptide CDMO Services Business (2020-2025)

11.1.5 Bachem Recent Development

11.2 PolyPeptide

11.2.1 PolyPeptide Company Details

11.2.2 PolyPeptide Business Overview

11.2.3 PolyPeptide Peptide CDMO Services Introduction

11.2.4 PolyPeptide Revenue in Peptide CDMO Services Business (2020-2025)

11.2.5 PolyPeptide Recent Development

11.3 CordenPharma

11.3.1 CordenPharma Company Details

11.3.2 CordenPharma Business Overview

11.3.3 CordenPharma Peptide CDMO Services Introduction

11.3.4 CordenPharma Revenue in Peptide CDMO Services Business (2020-2025)

11.3.5 CordenPharma Recent Development

11.4 AmbioPharm

11.4.1 AmbioPharm Company Details

11.4.2 AmbioPharm Business Overview

11.4.3 AmbioPharm Peptide CDMO Services Introduction

11.4.4 AmbioPharm Revenue in Peptide CDMO Services Business (2020-2025)

11.4.5 AmbioPharm Recent Development

11.5 USV Peptides

11.5.1 USV Peptides Company Details

11.5.2 USV Peptides Business Overview

11.5.3 USV Peptides Peptide CDMO Services Introduction

11.5.4 USV Peptides Revenue in Peptide CDMO Services Business (2020-2025)

11.5.5 USV Peptides Recent Development

11.6 Thermofischer

11.6.1 Thermofischer Company Details

11.6.2 Thermofischer Business Overview

11.6.3 Thermofischer Peptide CDMO Services Introduction

11.6.4 Thermofischer Revenue in Peptide CDMO Services Business (2020-2025)

11.6.5 Thermofischer Recent Development

11.7 Bio Basic

11.7.1 Bio Basic Company Details

11.7.2 Bio Basic Business Overview

11.7.3 Bio Basic Peptide CDMO Services Introduction

11.7.4 Bio Basic Revenue in Peptide CDMO Services Business (2020-2025)

11.7.5 Bio Basic Recent Development

11.8 JPT

11.8.1 JPT Company Details

11.8.2 JPT Business Overview

11.8.3 JPT Peptide CDMO Services Introduction

11.8.4 JPT Revenue in Peptide CDMO Services Business (2020-2025)

11.8.5 JPT Recent Development

11.9 Genscript

11.9.1 Genscript Company Details

11.9.2 Genscript Business Overview

11.9.3 Genscript Peptide CDMO Services Introduction

11.9.4 Genscript Revenue in Peptide CDMO Services Business (2020-2025)

11.9.5 Genscript Recent Development

11.10 Xinbang Pharma

11.10.1 Xinbang Pharma Company Details

11.10.2 Xinbang Pharma Business Overview

11.10.3 Xinbang Pharma Peptide CDMO Services Introduction

11.10.4 Xinbang Pharma Revenue in Peptide CDMO Services Business (2020-2025)

11.10.5 Xinbang Pharma Recent Development

11.11 ScinoPharm

11.11.1 ScinoPharm Company Details

11.11.2 ScinoPharm Business Overview

11.11.3 ScinoPharm Peptide CDMO Services Introduction

11.11.4 ScinoPharm Revenue in Peptide CDMO Services Business (2020-2025)

11.11.5 ScinoPharm Recent Development

11.12 SN Biopharm

11.12.1 SN Biopharm Company Details

11.12.2 SN Biopharm Business Overview

11.12.3 SN Biopharm Peptide CDMO Services Introduction

11.12.4 SN Biopharm Revenue in Peptide CDMO Services Business (2020-2025)

11.12.5 SN Biopharm Recent Development

11.13 CBL

11.13.1 CBL Company Details

11.13.2 CBL Business Overview

11.13.3 CBL Peptide CDMO Services Introduction

11.13.4 CBL Revenue in Peptide CDMO Services Business (2020-2025)

11.13.5 CBL Recent Development

11.14 Piramal Pharma

11.14.1 Piramal Pharma Company Details

11.14.2 Piramal Pharma Business Overview

11.14.3 Piramal Pharma Peptide CDMO Services Introduction

11.14.4 Piramal Pharma Revenue in Peptide CDMO Services Business (2020-2025)

11.14.5 Piramal Pharma Recent Development

11.15 CPC Scientific

11.15.1 CPC Scientific Company Details

11.15.2 CPC Scientific Business Overview

11.15.3 CPC Scientific Peptide CDMO Services Introduction

11.15.4 CPC Scientific Revenue in Peptide CDMO Services Business (2020-2025)

11.15.5 CPC Scientific Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Peptide CDMO Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of APIs and Intermediates

Table 3. Key Players of FDF

Table 4. Global Peptide CDMO Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Peptide CDMO Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Peptide CDMO Services Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Peptide CDMO Services Market Share by Region (2020-2025)

Table 8. Global Peptide CDMO Services Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Peptide CDMO Services Market Share by Region (2026-2031)

Table 10. Peptide CDMO Services Market Trends

Table 11. Peptide CDMO Services Market Drivers

Table 12. Peptide CDMO Services Market Challenges

Table 13. Peptide CDMO Services Market Restraints

Table 14. Global Peptide CDMO Services Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Peptide CDMO Services Market Share by Players (2020-2025)

Table 16. Global Top Peptide CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide CDMO Services as of 2024)

Table 17. Ranking of Global Top Peptide CDMO Services Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Peptide CDMO Services Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Peptide CDMO Services, Headquarters and Area Served

Table 20. Global Key Players of Peptide CDMO Services, Product and Application

Table 21. Global Key Players of Peptide CDMO Services, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Peptide CDMO Services Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Peptide CDMO Services Revenue Market Share by Type (2020-2025)

Table 25. Global Peptide CDMO Services Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Peptide CDMO Services Revenue Market Share by Type (2026-2031)

Table 27. Global Peptide CDMO Services Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Peptide CDMO Services Revenue Market Share by Application (2020-2025)

Table 29. Global Peptide CDMO Services Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Peptide CDMO Services Revenue Market Share by Application (2026-2031)

Table 31. North America Peptide CDMO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Peptide CDMO Services Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Peptide CDMO Services Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Peptide CDMO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Peptide CDMO Services Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Peptide CDMO Services Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Peptide CDMO Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Peptide CDMO Services Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Peptide CDMO Services Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Peptide CDMO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Peptide CDMO Services Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Peptide CDMO Services Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Peptide CDMO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Peptide CDMO Services Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Peptide CDMO Services Market Size by Country (2026-2031) & (US$ Million)

Table 46. Bachem Company Details

Table 47. Bachem Business Overview

Table 48. Bachem Peptide CDMO Services Product

Table 49. Bachem Revenue in Peptide CDMO Services Business (2020-2025) & (US$ Million)

Table 50. Bachem Recent Development

Table 51. PolyPeptide Company Details

Table 52. PolyPeptide Business Overview

Table 53. PolyPeptide Peptide CDMO Services Product

Table 54. PolyPeptide Revenue in Peptide CDMO Services Business (2020-2025) & (US$ Million)

Table 55. PolyPeptide Recent Development

Table 56. CordenPharma Company Details

Table 57. CordenPharma Business Overview

Table 58. CordenPharma Peptide CDMO Services Product

Table 59. CordenPharma Revenue in Peptide CDMO Services Business (2020-2025) & (US$ Million)

Table 60. CordenPharma Recent Development

Table 61. AmbioPharm Company Details

Table 62. AmbioPharm Business Overview

Table 63. AmbioPharm Peptide CDMO Services Product

Table 64. AmbioPharm Revenue in Peptide CDMO Services Business (2020-2025) & (US$ Million)

Table 65. AmbioPharm Recent Development

Table 66. USV Peptides Company Details

Table 67. USV Peptides Business Overview

Table 68. USV Peptides Peptide CDMO Services Product

Table 69. USV Peptides Revenue in Peptide CDMO Services Business (2020-2025) & (US$ Million)

Table 70. USV Peptides Recent Development

Table 71. Thermofischer Company Details

Table 72. Thermofischer Business Overview

Table 73. Thermofischer Peptide CDMO Services Product

Table 74. Thermofischer Revenue in Peptide CDMO Services Business (2020-2025) & (US$ Million)

Table 75. Thermofischer Recent Development

Table 76. Bio Basic Company Details

Table 77. Bio Basic Business Overview

Table 78. Bio Basic Peptide CDMO Services Product

Table 79. Bio Basic Revenue in Peptide CDMO Services Business (2020-2025) & (US$ Million)

Table 80. Bio Basic Recent Development

Table 81. JPT Company Details

Table 82. JPT Business Overview

Table 83. JPT Peptide CDMO Services Product

Table 84. JPT Revenue in Peptide CDMO Services Business (2020-2025) & (US$ Million)

Table 85. JPT Recent Development

Table 86. Genscript Company Details

Table 87. Genscript Business Overview

Table 88. Genscript Peptide CDMO Services Product

Table 89. Genscript Revenue in Peptide CDMO Services Business (2020-2025) & (US$ Million)

Table 90. Genscript Recent Development

Table 91. Xinbang Pharma Company Details

Table 92. Xinbang Pharma Business Overview

Table 93. Xinbang Pharma Peptide CDMO Services Product

Table 94. Xinbang Pharma Revenue in Peptide CDMO Services Business (2020-2025) & (US$ Million)

Table 95. Xinbang Pharma Recent Development

Table 96. ScinoPharm Company Details

Table 97. ScinoPharm Business Overview

Table 98. ScinoPharm Peptide CDMO Services Product

Table 99. ScinoPharm Revenue in Peptide CDMO Services Business (2020-2025) & (US$ Million)

Table 100. ScinoPharm Recent Development

Table 101. SN Biopharm Company Details

Table 102. SN Biopharm Business Overview

Table 103. SN Biopharm Peptide CDMO Services Product

Table 104. SN Biopharm Revenue in Peptide CDMO Services Business (2020-2025) & (US$ Million)

Table 105. SN Biopharm Recent Development

Table 106. CBL Company Details

Table 107. CBL Business Overview

Table 108. CBL Peptide CDMO Services Product

Table 109. CBL Revenue in Peptide CDMO Services Business (2020-2025) & (US$ Million)

Table 110. CBL Recent Development

Table 111. Piramal Pharma Company Details

Table 112. Piramal Pharma Business Overview

Table 113. Piramal Pharma Peptide CDMO Services Product

Table 114. Piramal Pharma Revenue in Peptide CDMO Services Business (2020-2025) & (US$ Million)

Table 115. Piramal Pharma Recent Development

Table 116. CPC Scientific Company Details

Table 117. CPC Scientific Business Overview

Table 118. CPC Scientific Peptide CDMO Services Product

Table 119. CPC Scientific Revenue in Peptide CDMO Services Business (2020-2025) & (US$ Million)

Table 120. CPC Scientific Recent Development

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

Table 124. Authors List of This Report

List of Figures

Figure 1. Peptide CDMO Services Picture

Figure 2. Global Peptide CDMO Services Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Peptide CDMO Services Market Share by Type: 2024 VS 2031

Figure 4. APIs and Intermediates Features

Figure 5. FDF Features

Figure 6. Global Peptide CDMO Services Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Peptide CDMO Services Market Share by Application: 2024 VS 2031

Figure 8. Commercial Case Studies

Figure 9. Academic Research Case Studies

Figure 10. Other Case Studies

Figure 11. Peptide CDMO Services Report Years Considered

Figure 12. Global Peptide CDMO Services Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Peptide CDMO Services Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Peptide CDMO Services Market Share by Region: 2024 VS 2031

Figure 15. Global Peptide CDMO Services Market Share by Players in 2024

Figure 16. Global Peptide CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 17. The Top 10 and 5 Players Market Share by Peptide CDMO Services Revenue in 2024

Figure 18. North America Peptide CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Peptide CDMO Services Market Share by Country (2020-2031)

Figure 20. United States Peptide CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Peptide CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Peptide CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Peptide CDMO Services Market Share by Country (2020-2031)

Figure 24. Germany Peptide CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Peptide CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Peptide CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Peptide CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Peptide CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Peptide CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Peptide CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Peptide CDMO Services Market Share by Region (2020-2031)

Figure 32. China Peptide CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Peptide CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Peptide CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Peptide CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Peptide CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Peptide CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Peptide CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Peptide CDMO Services Market Share by Country (2020-2031)

Figure 40. Mexico Peptide CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Peptide CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Peptide CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Peptide CDMO Services Market Share by Country (2020-2031)

Figure 44. Turkey Peptide CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Peptide CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Peptide CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Bachem Revenue Growth Rate in Peptide CDMO Services Business (2020-2025)

Figure 48. PolyPeptide Revenue Growth Rate in Peptide CDMO Services Business (2020-2025)

Figure 49. CordenPharma Revenue Growth Rate in Peptide CDMO Services Business (2020-2025)

Figure 50. AmbioPharm Revenue Growth Rate in Peptide CDMO Services Business (2020-2025)

Figure 51. USV Peptides Revenue Growth Rate in Peptide CDMO Services Business (2020-2025)

Figure 52. Thermofischer Revenue Growth Rate in Peptide CDMO Services Business (2020-2025)

Figure 53. Bio Basic Revenue Growth Rate in Peptide CDMO Services Business (2020-2025)

Figure 54. JPT Revenue Growth Rate in Peptide CDMO Services Business (2020-2025)

Figure 55. Genscript Revenue Growth Rate in Peptide CDMO Services Business (2020-2025)

Figure 56. Xinbang Pharma Revenue Growth Rate in Peptide CDMO Services Business (2020-2025)

Figure 57. ScinoPharm Revenue Growth Rate in Peptide CDMO Services Business (2020-2025)

Figure 58. SN Biopharm Revenue Growth Rate in Peptide CDMO Services Business (2020-2025)

Figure 59. CBL Revenue Growth Rate in Peptide CDMO Services Business (2020-2025)

Figure 60. Piramal Pharma Revenue Growth Rate in Peptide CDMO Services Business (2020-2025)

Figure 61. CPC Scientific Revenue Growth Rate in Peptide CDMO Services Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions